<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - Remoxy</title>
<description>International Business News - Remoxy</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>Durect submits new drug application for Remoxy</title>
  <description>Drug developer Durect Corp. said Tuesday it applied for regulatory approval of Remoxy, designed to be an abuse-resistant form of oxycodone. The company submitted a new drug application to the U.S. Food and Drug Administration to use Remoxy, an investigational drug, as a long-acting oral form of oxycodone, as a treatment for moderate to severe pain.</description>
    <link>http://www.ibtimes.com/articles/20080610/durect-submits-new-drug-application-for-remoxy.htm</link> 
  <pubDate>Tue, 10 Jun 2008 18:39:46 EDT</pubDate>
  </item>


</channel>
</rss>